Agios Pharmaceuticals Inc (AGIO)
44.82
-0.06
(-0.12%)
USD |
NASDAQ |
Nov 04, 16:00
44.82
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Net Income (Annual): -352.09M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -352.09M |
| December 31, 2022 | -231.80M |
| December 31, 2021 | 1.605B |
| December 31, 2020 | -327.37M |
| December 31, 2019 | -411.47M |
| December 31, 2018 | -346.03M |
| December 31, 2017 | -314.67M |
| Date | Value |
|---|---|
| December 31, 2016 | -198.47M |
| December 31, 2015 | -117.73M |
| December 31, 2014 | -53.50M |
| December 31, 2013 | -39.41M |
| December 31, 2012 | -20.10M |
| December 31, 2011 | -23.71M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-411.47M
Minimum
2019
1.605B
Maximum
2021
56.40M
Average
-327.37M
Median
2020
Net Income (Annual) Benchmarks
| Pfizer Inc | 2.119B |
| Regeneron Pharmaceuticals Inc | 3.954B |
| Ligand Pharmaceuticals Inc | 52.15M |
| ADMA Biologics Inc | -28.24M |
| AnaptysBio Inc | -163.62M |